Medicare Negotiation: What the First 10 Selected Drugs Tell Us About the Program’s Future

ATI Advisory is hosting an upcoming webinar titled, “Medicare Negotiation: What the First 10 Selected Drugs Tell Us About the Program’s Future.” This webinar will discuss what this list of drugs says about the trajectory of the Medicare prescription drug negotiation program, how that could affect supply chain economics, and how manufacturers might think about new drug development going forward.

Speakers:

• Anne Tumlinson, CEO, ATI Advisory
• Anna Kaltenboeck, Principal and Head of Prescription Drug Reimbursement, ATI Advisory

This webinar will take place on Wednesday, September 13 at 2:00 p.m. ET.